K Pharma
Pioneering the future of medicine with innovative neuro regenerative therapies and advanced iPS drug discovery.
Pioneering the future of medicine with innovative neuro regenerative therapies and advanced iPS drug discovery.
K Pharma is a health care startup, founded in 2016, that is pioneering the future of medicine through innovative neuro regenerative therapies and advanced iPS drug discovery. The company creates pharmaceuticals by utilizing early-stage neuro regenerative medicine and iPS drug discovery, and conducts research, manufacturing, and development of medical products and pharmaceuticals. The company recently received a significant ¥1.55B Venture Round investment on 24 May 2022. The investors in this round include Daiwa Corporate Investment, ITOUCH Technology Ventures, Keio Innovation Initiative, ICMG Partners, and Kagoshima Development. With its focus on pioneering medical advancements in neuro regenerative therapies and iPS drug discovery, K Pharma is poised for further growth and innovation in the field of pharmaceuticals and healthcare.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | ¥1.55B | 5 |
|
24 May 2022 |
We care about your data, and we'd love to use cookies make your experience better.
